Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Minimally Invasive Coronary Artery Bypass Supported by Cangrelor

NCT07514962 is registered in ClinicalTrials.gov with Cardiocentro Ticino as lead sponsor.

NCT NCT07514962
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07514962 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Minimally Invasive Coronary Artery Bypass Supported by Cangrelor
Lead sponsor
Cardiocentro Ticino
Phase
Observational
Overall status
Recruiting
Start date
May 12, 2024
Completion date
January 1, 2028
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antiplatelet therapy, coronary artery disease, minimally invasive coronary revascularization surgery